RMTI — ROCKWELL MEDICAL, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1041024 ·
Last close
$7.90
Market Cap
$31.84M
52W High
$8.10
52W Low
$4.89
ADV30
30,381
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 17,336,000 | 2,897,000 | -1,480,000 | -1,605,000 | 57,423,000 | 9,609,000 | 21,566,000 |
| Dec 2025 | 18,346,000 | 3,878,000 | -398,000 | -554,000 | 57,145,000 | 10,711,000 | 20,164,000 |
| Sep 2025 | 15,927,000 | 2,272,000 | -1,584,000 | -1,753,000 | 57,486,000 | 13,610,000 | 20,466,000 |
| Jun 2025 | 16,071,000 | 2,503,000 | -1,349,000 | -1,492,000 | 52,625,000 | 12,482,000 | 22,216,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$2,661,000
Investing CF
$-8,665,000
Financing CF
$4,222,000
CapEx
$-904,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.50
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-404,597,000
Inventory
$3,055,000
Receivables
$8,825,000
ST Investments
$14,281,000
EBIT TTM
$-4,275,000
Pretax Income TTM
$-5,404,000
Interest Exp TTM
$1,129,000
Analysts
2
Yahoo Snapshot (yfinance, live)
Total Revenue
$69,389,000
EBITDA
$-2,430,000
Free Cash Flow
$350,375
Enterprise Value
$20,976,674
Total Cash
$24,797,000
Total Debt
$13,933,000
Shares Out
4,030,465
Trailing EPS
$-1.32
Book Value
$9.09
ROE
-15.5%
ROA
-5.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 69,258,000 | -4,691,000 | -5,314,000 | 57,145,000 | 20,164,000 | — | -659,000 |
| Dec 2024 | 101,489,000 | 608,000 | -480,000 | 59,208,000 | 26,622,000 | — | 4,202,000 |
| Dec 2023 | 83,612,000 | -6,670,000 | -8,439,000 | 52,173,000 | 30,882,000 | — | -9,412,000 |
| Dec 2022 | 72,810,000 | -16,780,000 | -18,679,000 | 46,635,000 | 32,529,000 | — | -16,929,000 |
TTM Snapshot
Revenues TTM
$25,832,000
NetIncome TTM
$343,000
OpCashFlow TTM
$0
Assets (Latest)
$59,208,000
Forward EPS
$0.07
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| KYNB | KYNTRA BIO, INC. | $32.31M | $7.98 | — |
| NNVC | NANOVIRICIDES, INC. | $32.42M | $1.27 | — |
| IGC | IGC Pharma, Inc. | $31.08M | $0.30 | — |
| ATNM | Actinium Pharmaceuticals, Inc. | $32.94M | $1.05 | — |
| MIRA | MIRA PHARMACEUTICALS, INC. | $33.12M | $0.79 | — |
News headlines (Yahoo Finance, 1h cache)
Rockwell Medical (RMTI) Q2 2026 Earnings Call Transcript
2026-08-14 02:59 · Yahoo
Rockwell Medical Inc (RMTI) (Q2 2026) Earnings Call Highlights: Revenue Up 11% and Cash Flow ...
2026-08-13 23:09 · Yahoo
Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates
2026-08-13 11:10 · Yahoo
Rockwell Medical Announces Second Quarter 2026 Results
2026-08-13 10:00 · Yahoo
Rockwell Medical Regains Compliance with Nasdaq Listing Requirements
2026-07-20 10:00 · Yahoo
Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026
2026-07-16 10:00 · Yahoo
Rockwell Medical Announces First Reverse Stock Split In 4 Years – Nasdaq Compliance In Focus As Shares Haven’t Traded Above $1 Since March
2026-06-29 11:40 · Yahoo
Rockwell Medical Announces 1-for-10 Reverse Stock Split
2026-06-29 10:00 · Yahoo
RMTI Q1 2026 Earnings Transcript
2026-05-08 15:11 · Yahoo
Rockwell Medical (RMTI) Reports Q1 Loss, Misses Revenue Estimates
2026-05-07 11:10 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.